搜索临床试验以:H2 receptor antagonist
总计41583个结果
-
University of AarhusAarhus University Hospital; Zimmer Biomet完全的
-
Emory UniversityNational Institute of Mental Health (NIMH)完全的
-
University of AarhusAarhus University Hospital; Zimmer Biomet; Vejle Hospital主动,不招人
-
University of Southern DenmarkDePuy Orthopaedics; Zimmer Biomet; Region Zealand; Ministry of the Interior and Health, Denmark未知
-
Tel-Aviv Sourasky Medical CenterTel Aviv Medical Center完全的
-
Johnson & Johnson Consumer and Personal Products...完全的
-
Instituto Nacional de Cancerologia de Mexico招聘中
-
National Taiwan University HospitalNational Science Council, Taiwan完全的
-
Children's Hospital Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
Ache Laboratorios Farmaceuticos S.A.撤销
-
Washington State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National...完全的
-
ANRS, Emerging Infectious DiseasesBristol-Myers Squibb完全的
-
Weill Medical College of Cornell UniversityThe New York Community Trust完全的
-
University of California, Los Angeles招聘中
-
Centre de Recherche de l'Institut Universitaire...完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Centocor Ortho Biotech Services, L.L.C.完全的
-
Patrick C. Johnson, MDAstraZeneca招聘中难治性 B 细胞非霍奇金淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 (DLBCL) | 3b 级滤泡性淋巴瘤 | 难治性侵袭性 B 细胞淋巴瘤 | 侵袭性 B 细胞 NHL | 从头或转化的惰性 B 细胞淋巴瘤 | DLBCL,Nos 遗传亚型 | 富含 T 细胞/组织细胞的大 B 细胞淋巴瘤 | EBV 阳性 DLBCL,编号 | 原发性纵隔 [胸腺] 大 B 细胞淋巴瘤 (PMBCL) | 高级 B 细胞淋巴瘤,编号 | C-MYC/BCL6 双重打击高级别 B 细胞淋巴瘤 | C-MYC/BCL2 双重打击高级别 B 细胞淋巴瘤美国